Insider · CIK 0001492386

DeSilva Nishan M

Reports to the SEC for 4 companies · FREDERICK, MD

sec.gov

Transactions

Companies

Filings

CIK

0001492386

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	RNACCartesian Therapeutics, Inc.A Award	Director	AAward	+2,600 sh	—	—	11,366
2026-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2025-01-02	RNACCartesian Therapeutics, Inc.A Award	Director	AAward	+2,600 sh	—	—	8,766
2025-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,800 sh	—	—	7,800
2024-01-02	RNACCartesian Therapeutics, Inc.A Award	Director	AAward	+178K sh	—	—	185,000
2024-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+228K sh	—	—	228,000
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−80K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	$0.93	−$69.8K	0
2023-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2022-01-03	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-12-02	RNACCartesian Therapeutics, Inc.P Purchase	Director	PPurchase	+7,000 sh	$2.96	+$20.7K	7,000
2021-06-23	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2015-05-14	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	+20.9K sh	$74.42	+$1.56M	43,220
2015-05-14	LGNDLIGAND PHARMACEUTICALS INCS Sale	VP, Finance & Strategy and CFO	SSale	−20.9K sh	$83.84	−$1.76M	22,282
2015-05-14	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	−20.9K sh	—	—	24,062
2015-05-13	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	+12.1K sh	$21.92	+$266K	34,430
2015-05-13	LGNDLIGAND PHARMACEUTICALS INCS Sale	VP, Finance & Strategy and CFO	SSale	−12.1K sh	$83.23	−$1.01M	22,282
2015-05-13	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	+11.8K sh	$14.47	+$170K	34,039
2015-05-13	LGNDLIGAND PHARMACEUTICALS INCS Sale	VP, Finance & Strategy and CFO	SSale	−11.8K sh	$83.32	−$980K	22,282
2015-05-13	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	−11.8K sh	—	—	64,029
2015-05-13	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	−12.1K sh	—	—	23,546
2015-05-12	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	+14.2K sh	$14.47	+$206K	36,496
2015-05-12	LGNDLIGAND PHARMACEUTICALS INCS Sale	VP, Finance & Strategy and CFO	SSale	−14.2K sh	$84.44	−$1.2M	22,282
2015-05-12	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	+9,306 sh	$21.92	+$204K	31,588
2015-05-12	LGNDLIGAND PHARMACEUTICALS INCS Sale	VP, Finance & Strategy and CFO	SSale	−9,306 sh	$84.91	−$790K	22,282
2015-05-12	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	−14.2K sh	—	—	75,786
2015-05-12	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	VP, Finance & Strategy and CFO	MExercise/Conversion	−9,306 sh	—	—	35,694
2015-02-10	LGNDLIGAND PHARMACEUTICALS INCS Sale	VP, Finance & Strategy and CFO	SSale	−2,300 sh	$56.34	−$130K	16,359
2015-02-10	LGNDLIGAND PHARMACEUTICALS INCA Award	VP, Finance & Strategy and CFO	AAward	+5,923 sh	—	—	22,282
2015-02-10	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+20.9K sh	$56.26	+$1.17M	20,873
2014-02-12	LGNDLIGAND PHARMACEUTICALS INCA Award	VP, Finance & Strategy and CFO	AAward	+3,000 sh	—	—	18,659
2014-02-12	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+35K sh	$74.42	+$2.6M	35,000
2014-02-12	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+5,000 sh	$74.42	+$372K	40,000
2014-02-12	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+5,000 sh	$74.42	+$372K	45,000
2013-06-28	LGNDLIGAND PHARMACEUTICALS INCP Purchase	VP, Finance & Strategy and CFO	PPurchase	+169 sh	$17.36	+$2,933.84	15,659
2013-02-15	LGNDLIGAND PHARMACEUTICALS INCA Award	VP, Finance & Strategy and CFO	AAward	+5,000 sh	—	—	15,490
2013-02-15	LGNDLIGAND PHARMACEUTICALS INC · Incentive Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+4,374 sh	$21.92	+$95.9K	4,374
2013-02-15	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+40.6K sh	$21.92	+$891K	40,626
2012-12-31	LGNDLIGAND PHARMACEUTICALS INCJ Other	VP, Finance & Strategy and CFO	JOther	+490 sh	$14.54	+$7,122.15	10,490
2012-02-09	LGNDLIGAND PHARMACEUTICALS INCA Award	VP, Finance & Strategy and CFO	AAward	+10K sh	—	—	10,000
2012-02-09	LGNDLIGAND PHARMACEUTICALS INC · Incentive Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+30.8K sh	$14.47	+$445K	30,765
2012-02-09	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+44.2K sh	$14.47	+$640K	44,235
2012-02-09	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	VP, Finance & Strategy and CFO	AAward	+15K sh	$14.47	+$217K	59,235
2011-12-13	ALLOS THERAPEUTICS INCA Award	Director	AAward	+35K sh	—	—	35,000
2011-06-21	ALLOS THERAPEUTICS INCStock Options (Right to Buy)A Award	Director	AAward	+20K sh	$2.06	+$41.2K	20,000
2011-04-01	Talon Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2010-07-30	Talon Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Jan 64
DeSilva Nishan M0001453687-26-000039
SEC(opens sec.gov)
Jan 64
DeSilva Nishan M0001453687-25-000015
SEC(opens sec.gov)
Jan 44
DeSilva Nishan M0001453687-24-000020
SEC(opens sec.gov)
Nov 154
DeSilva Nishan M0001453687-23-000086
SEC(opens sec.gov)
Jan 44
DeSilva Nishan M0001453687-23-000020
SEC(opens sec.gov)
Jan 54
DeSilva Nishan M0001453687-22-000018
SEC(opens sec.gov)
Dec 64
DeSilva Nishan M0001453687-21-000163
SEC(opens sec.gov)
Jul 94
DeSilva Nishan M0001453687-21-000090
SEC(opens sec.gov)
May 144
LIGAND PHARMACEUTICALS INC0000886163-15-000064
SEC(opens sec.gov)

Companies

Address

C/O CARTESIAN THERAPEUTICS, INC. 7495 NEW HORIZON WAY

FREDERICK, MD, 21703